BioSig Technologies, Inc. (BSGM) financial statements (2022 and earlier)

Company profile

Business Address 55 GREENS FARMS ROAD
WESTPORT, CT 06880
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,70028,26812,1094,4501,5481,056
Cash and cash equivalents11,70028,26812,1094,4501,5481,056
Inventory, net of allowances, customer advances and progress billings1,881768578   
Inventory1,881768578   
Prepaid expense354301141178117134
Other current assets 301    
Other undisclosed current assets(41)(301)    
Total current assets:13,89429,33712,8274,6291,6651,190
Noncurrent Assets
Operating lease, right-of-use asset604306714
Property, plant and equipment652289180441924
Intangible assets, net (including goodwill)327347366270  
Intangible assets, net (excluding goodwill)327347366270  
Prepaid expense 527   
Deposits noncurrent assets42102102541728
Other undisclosed noncurrent assets 0    
Total noncurrent assets:1,6251,0491,3903683652
TOTAL ASSETS:15,51930,38614,2174,9971,7001,242
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,179  955473373
Accrued liabilities243  6394123
Employee-related liabilities552  395  
Interest and dividends payable82  243  
Settlement liabilities613  131313
Other undisclosed accounts payable and accrued liabilities689  241366236
Deferred revenue32  
Derivative instruments and hedges, liabilities    2,3581,937
Due to related parties8631740322716
Deferred revenue and credits 3
Other undisclosed current liabilities2794,7911,9902111,106630
Total current liabilities:2,5765,1082,0301,1983,9652,959
Noncurrent Liabilities
Long-term debt and lease obligation3731311   
Operating lease, liability3731311
Liabilities, other than long-term debt5     
Deferred revenue5  
Other undisclosed noncurrent liabilities 5,1082,030   
Total noncurrent liabilities:3785,1092,341   
Other undisclosed liabilities (5,108)(2,030)   
Total liabilities:2,9545,1092,3411,1983,9652,959
Commitments and contingencies    30 
Temporary equity, carrying amount1051052154759851,070
Stockholders' equity
Stockholders' equity attributable to parent, including:12,24124,37011,1473,324(3,250)(2,787)
Common stock363123172923
Common stock, share subscribed but unissued, subscriptions receivable   (30)  
Additional paid in capital201,127181,344115,91074,03953,21641,019
Accumulated deficit(188,922)(157,005)(104,787)(70,732)(56,525)(43,829)
Other undisclosed stockholders' equity attributable to parent   3030 
Stockholders' equity attributable to noncontrolling interest219802515   
Other undisclosed stockholders' equity (0)    
Total stockholders' equity:12,46025,17211,6613,324(3,250)(2,787)
Other undisclosed liabilities and equity    (30) 
TOTAL LIABILITIES AND EQUITY:15,51930,38614,2174,9971,7001,242

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues441     
Cost of revenue
(Cost of Goods and Services Sold)
(199)     
Gross profit:242     
Operating expenses(33,653)(59,184)(34,604)(17,262)(12,906)(11,164)
Other undisclosed operating loss (0)    
Operating loss:(33,411)(59,184)(34,604)(17,262)(12,906)(11,164)
Nonoperating expense     (423)
Interest and debt expense553     
Other undisclosed income from continuing operations before equity method investments, income taxes 4413311211 
Loss from continuing operations before equity method investments, income taxes:(32,858)(59,140)(34,471)(17,251)(12,696)(11,587)
Other undisclosed income from continuing operations before income taxes2     
Loss from continuing operations before income taxes:(32,856)(59,140)(34,471)(17,251)(12,696)(11,587)
Other undisclosed loss from continuing operations (44)    
Loss before gain (loss) on sale of properties:(32,856)(59,184)(34,471)(17,251)(12,696)(11,587)
Other undisclosed net income 44    
Net loss:(32,856)(59,140)(34,471)(17,251)(12,696)(11,587)
Net income (loss) attributable to noncontrolling interest9396,922(416)   
Other undisclosed net income attributable to parent 0807   
Net loss attributable to parent:(31,917)(52,218)(34,080)(17,251)(12,696)(11,587)
Other undisclosed net loss available to common stockholders, basic(9)(14)(416)(885)(120)(110)
Net loss available to common stockholders, basic:(31,926)(52,232)(34,496)(18,136)(12,816)(11,697)
Convertible preferred dividends    117 
Net loss available to common stockholders, diluted:(31,926)(52,232)(34,496)(18,136)(12,699)(11,697)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(32,856)(59,140)(34,471)(17,251)(12,696)(11,587)
Comprehensive loss:(32,856)(59,140)(34,471)(17,251)(12,696)(11,587)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest9396,922(416)   
Comprehensive loss, net of tax, attributable to parent:(31,917)(52,218)(34,887)(17,251)(12,696)(11,587)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: